Sep 27 |
Biotech IPOs return as sector recovers after funding overhang
|
Sep 19 |
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
|
Sep 13 |
Biotech IPO Shares Climb in Debuts After Deals Upsized
|
Sep 13 |
Bicara, MBX Bio lead gainers as biotech trio makes trading debut
|
Sep 13 |
Zenas BioPharma prices $225M IPO at $17 per share
|
Sep 13 |
Bicara Leads Trio of US Biotech IPOs Raising $703 Million
|
Sep 13 |
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
|
Sep 9 |
IPO Roundup: Bicara Therapeutics, Kairos Pharma and more
|